Bluefin Capital Management’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bluefin Capital Management’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-89,180	Closed	-$1.74M	–	552
2022 Q4	$1.74M	Buy	+89,180	New	+$1.79M	0.26%	62

Bluefin Capital Management's ELAT Position: Q1 2023 in Review

Bluefin Capital Management sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 89,180 shares — an estimated $1.74M sold.

Bluefin Capital Management first reported a position in ELAT in Q4 2022 and held it in 1 quarter. The position peaked at $1.74M in Q4 2022. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

Bluefin Capital Management reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
Bluefin Capital Management sold 89,180 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $1.74M.
Bluefin Capital Management first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q4 2022 and held it in 1 quarter.
Bluefin Capital Management's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $1.74M in Q4 2022.
0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Bluefin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.